Nicole Fitzgerald, PhD

Postdoc @ColumbiaMSPH | PhD @UFPHHP | Substance use epidemiology

[Joseph Palamar @JosephPalamar]

Our new paper published today: major increase in #fentanyl seizures through 2023 and half of seizures are now in pill form. Over 115 million pills seized in 2023 @NIDAnews @NDEWSnews @nyulangone @LCottler @nd_fitzgerald @DanCiccarone
https://t.co/amA5FtzFLK

[Linda B. Cottler @LCottler]

The @LCottler Lab is so happy to announce the graduation of @nd_fitzgerald from our doctoral program in epidemiology. She is beginning her new chapter in July. I’m so proud of @nd_fitzgerald. Congratulations!!

[Joseph Palamar @JosephPalamar]

Our new paper: in 2017, an estimated 23% of ecstasy users in the nightclub/festival scene in NYC had tested their ecstasy, and this estimate increased to 43% in 2022. Suspected adulteration with meth or "bath salts" decreased @nd_fitzgerald @NDEWSnews
https://t.co/Hk16CNLkwq

[Journal of Studies on Alcohol and Drugs @JSADJournal]

Seizures of Psychedelic Mushrooms Rise in U.S. as Demand Grows (by @londonoe)
@NIDAnews @JosephPalamar @nd_fitzgerald @epi_kerrykeyes @LCottler @nyugrossman @UFPHHP @ONDCP @ColumbiaMSPH @realJoshSiegel
https://t.co/HJeNYy5vNT

[Joseph Palamar @JosephPalamar]

Our new paper: #ketamine related poisonings in the US increased through 2021 but are still somewhat rare. Not the most dangerous drug but something we need to keep an eye on. Not to be mixed with alcohol or GHB
@NDEWSnews @LCottler @nd_fitzgerald
https://t.co/zxGkVoO2g8

[Linda B. Cottler @LCottler]

@CPDDorg @NDEWSnews @JosephPalamar At the #cpdd22 plenary today, Director of NIDA presented our NDEWS paper on increases in seizures of fentanyl. https://t.co/cbYkOqakRh

[Nicole Fitzgerald, PhD @nd_fitzgerald]

@NathanRexSmith Thanks, Nathan!

[Linda B. Cottler @LCottler]

Prescription stimulant brand name recognition among a national sample of 10‐ to 18‐year‐old youth - Cottler - 2021 - International Journal of Methods in Psychiatric Research - Wiley Online Library https://t.co/eQQr6wXKuD

[Joseph Palamar @JosephPalamar]

Free version of our new paper in @DrugAlcoholDep: we demonstrated the clinical utility of DSM-based criteria for ketamine. Continued use despite physical or psychological problems most common criterion (59%) @NDEWSnews @nd_fitzgerald @LCottler @CannaBoss
https://t.co/tluD3YjV0A

[NPS Discovery @ CFSRE @NPSDiscovery]

📖 Online surveillance of novel psychoactive substances (#NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures … available now in the @ijdrugpolicy via #open #access ‼️

⬇️⬇️⬇️

🔗: https://t.co/e92OlJyB5D

[Joseph Palamar @JosephPalamar]

Free version of our new @NDEWSnews paper. Reddit discussions about new psychoactive substances tend to predict exposure patterns in the US. This was the case with various opioids, bath salts, and benzos
@alexkrotulski @NPSDiscovery @LCottler @ijdrugpolicy
https://t.co/Rhmo0sehyb

[Joseph Palamar @JosephPalamar]

Free access to our new paper: agreement that cocaine can be contaminated with fentanyl increased among EDM nightclub attendees in NYC between 2018 & 2019. Continued education and drug checking needed @nd_fitzgerald @LCottler @NDEWSnews @ijdrugpolicy
https://t.co/cNQ6PLeCao

[UF Center for Addiction Research & Education @UFCARE]

We are proud to have over 30 @UF presentations at #CPDD21, featuring many of our members: @LCottler, @cookbob1127, @nd_fitzgerald, @marilyn_horta, @CatalinaLopezQ1, @clstriley, @yanningwang #AcademicTwitter

[Joseph Palamar @JosephPalamar]

Our new review paper about #DrugChecking at dance festivals. Moving beyond self-selected samples of attendees would lead to more generalizable results. People who normally wouldn't test need to be reached @LCottler @nd_fitzgerald @epi_kerrykeyes @NDEWSnews
https://t.co/pPWLE7tUHW

[Joseph Palamar @JosephPalamar]

Introducing our new @NDEWSnews (NDEWS) Twitter account. We at @UF and @pophealthNYC have begun overseeing a new iteration of this center to monitor emerging drug trends in the US. Please follow us for news about drug trends and other important drug-related topics